Back to search

Article

MicroRNA as a predictor of efficacy and safety of clozapine in patients with treatment resistant schizophrenia

2025-02-06

Abstract excerpt

<title>Abstract</title> <p>Clozapine is the only antipsychotic effective for treatment-resistant schizophrenia. However, it is only effective in 40% of patients with treatment resistant and is associated with a large number of adverse drug reactions. Personalization of clozapine therapy is of great importance to clinical psychiatry. MicroRNA expression is a promising biomarker for predicting the efficacy and safe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1fa43ded-fc1d-5124-8aec-c5d00f762f35
DOI
10.21203/rs.3.rs-5946023/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MicroRNA as a predictor of efficacy and safety of clozapine in patients with treatment resistant schizophreniaDOI 10.21203/rs.3.rs-5946023/v1
Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene StudySemantic proximity
Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an updateSemantic proximity
MicroRNAs in mental health: from biological underpinnings to potential therapies.Semantic proximity
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity
A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.Semantic proximity
Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatmentSemantic proximity
Dysregulation of miRNAs in Schizophrenia in an Egyptian Patient PopulationSemantic proximity
Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant SchizophreniaSemantic proximity
MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.Semantic proximity
MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.Semantic proximity
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity
Identification of serum microRNAs as diagnostic biomarkers for schizophreniaSemantic proximity
Select a neighboring publication to make it the new centre.